Healthcare

4DMedical develops software designed to show how the lungs function, rather than simply providing an anatomical picture of the lungs.

Artrya (ASX:AYA) is moving into a different stage of its US expansion. The Perth-based medical technology company is no longer focused only on obtaining regulatory clearances for its cardiac imaging software; it is now trying to turn those approvals into routine clinical use, hospital …

Diagnosing autism can involve lengthy specialist waiting periods, repeated assessments and substantial costs for families and healthcare systems. BlinkLab (ASX:BB1) is developing a different approach built around technology already available in most households: the smartphone.

Oneview Healthcare (ASX:ONE) has spent more than a decade developing technology around one of the most visible but often overlooked pieces of hospital infrastructure: the screen positioned beside a patient’s bed.

• FY2026 group revenue reached approximately A$4.3 million, a 210% increase on A$1.3 million the prior year, with Q4 alone contributing about A$1.53 million as clinics moved into genuine patient throughput.

• Second-quarter FY26 revenue reached a record A$8.0 million, up 21% year-on-year (15% in constant currency), with first-half revenue of A$16 million rising 17% and annualised recurring revenue climbing 12% to A$36.8 million.

OncoSil Medical (ASX:OSL) is developing a targeted internal radiation treatment designed for difficult-to-treat cancers, with current activities spanning regulatory approvals, clinical development and commercial expansion.